Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

150.49 +4.79 (+3.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Krystal Biotech, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
A Glimpse Into The Expert Outlook On Krystal Biotech Through 10 Analysts
 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
 
Via Benzinga
What 8 Analyst Ratings Have To Say About Krystal Biotech
 
Via Benzinga
Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results
 
Via Benzinga
Krystal (KRYS) Q2 Profit Jumps 143%
Via The Motley Fool
Earnings Scheduled For August 4, 2025
 
Via Benzinga
Earnings Outlook For Krystal Biotech
 
Via Benzinga
Analyst Expectations For Krystal Biotech's Future
 
Via Benzinga
Peering Into Krystal Biotech's Recent Short Interest
 
Via Benzinga
KRYSTAL BIOTECH INC (NASDAQ:KRYS) Q2 2025 Earnings Beat Estimates as VYJUVEK Drives Strong Revenue Growth
Krystal Biotech (KRYS) Q2 2025 earnings beat estimates with $96M revenue and $1.29 EPS, driven by VYJUVEK success. Shares rose 4% pre-market. 
Via Chartmill
Topics Earnings
Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
 
Via Benzinga
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
Via The Motley Fool
Topics Artificial Intelligence
What Does the Market Think About Krystal Biotech?
 
Via Benzinga
Earnings Scheduled For May 6, 2025
 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
 
Via Benzinga
Is the Market Bullish or Bearish on Krystal Biotech?
 
Via Benzinga
Demystifying Krystal Biotech: Insights From 7 Analyst Reviews
 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Experts
 
Via Benzinga
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next 
Via MarketBeat
Topics Earnings
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
 
Via Benzinga
Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease
Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million. 
Via Benzinga
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
 
Via Benzinga
Demystifying Krystal Biotech: Insights From 7 Analyst Reviews
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.